Wellington Management International Limited

Wellington Management International Limited, also known legally as WELLINGTON MANAGEMENT INTERNATIONAL LIMITED, is an Other (specify) with 301 employees, including 112 in advisory roles. Although the number of clients served is unknown, the firm's SEC status is Approved, with registration dating back to Jan 2, 2013.

• AMY BETH KRAMER

  DIRECTOR owns less than 5%

• CARL DIRK ENDERLEIN

  DIRECTOR owns less than 5%

• EDWARD JOSEPH STEINBORN

  DIRECTOR owns less than 5%

• GRAHAM WILLIAM ALEXANDER STONE

  CHIEF COMPLIANCE OFFICER owns less than 5%

• HENRY EDWARD DUFFY

  DIRECTOR owns less than 5%

• JOHN PETER PARSONS

  DIRECTOR owns less than 5%

• LUCINDA MARIA MARRS

  DIRECTOR owns less than 5%

• LUKE BARNABY STELLINI

  DIRECTOR owns less than 5%

• NATASHA LOUISE BROOK-WALTERS

  DIRECTOR owns less than 5%

• PHILLIP H PERELMUTER

  CHIEF EXECUTIVE OFFICER, DIRECTOR owns less than 5%

• RAY EUGENE HELFER

  DIRECTOR owns less than 5%

• STEFAN KURT HASELWANDTER

  DIRECTOR owns less than 5%

• SUSANNE BALLAUFF

  DIRECTOR owns less than 5%

• WELLINGTON MANAGEMENT GLOBAL HOLDINGS, LTD.

  SHAREHOLDER owns 75% or more

• YOLANDA CRISTINA COURTINES

  DIRECTOR owns less than 5%

• WELLINGTON GROUP HOLDINGS LLP

  MANAGING PARTNER owns 75% or more

• WELLINGTON INVESTMENT ADVISORS HOLDINGS LLP

  SHAREHOLDER owns 75% or more

• WELLINGTON MANAGEMENT GROUP LLP

  MANAGING PARTNER owns 75% or more

• Longview Partners LLP
• 36 South Capital Advisors LLP
• Macquarie Investment Management Europe Limited
• Quantmetrics Capital Management LLP
• James Hambro & Partners LLP
• Cairn Loan Investments LLP
• Federated Investors UK LLP
• AHL Partners LLP
• Farallon Capital Europe LLP
• CDAM UK Ltd

• Wellington Management Group's Q3 and Q4 2022 Fund Holdings Comparison
• Vanguard to surrender some of its corporate voting power to external fund managers
• Invesco and Wellington eye global adoption of Mifid II
• Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisition

• ACCO BRANDS CORP $11,449k